VENESS ADAM M (VP, General Counsel and Sec.) sold 6.9% of their position (1.41K shares) of ACCELERON PHARMA INC on the open market
Open‑market sale worth $183.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/9/2021ACC: 0001179110-21-008690
Officer· VP, General Counsel and Sec.
Since Jun 2019
-2K
Net shares
Net seller
$259.6K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
2K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−587.00
Price / share
$129.36
Trade value
$75.93K
% of position
2.8%
9/7/2021
20.92K→20.34K
Common Stock
Direct
Shares
−6.00
Price / share
$130.00
Trade value
$780.00
% of position
0.0%
9/8/2021
20.34K→20.33K
Common Stock
Direct
Shares
−1.41K
Price / share
$130.00
Trade value
$182.91K
% of position
6.9%
9/9/2021
20.33K→18.92K
Total
Net shares
−2K
Net value
-$259.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/7/2021 | F · Tax Withholding | −587.00 | $129.36 | $75.93K | 2.8% | 20.92K | 20.34K |
| Common Stock Direct | 9/8/2021 | S · Sale | −6.00 | $130.00 | $780.00 | 0.0% | 20.34K | 20.33K |
| Common Stock Direct | 9/9/2021 | S · Sale | −1.41K | $130.00 | $182.91K | 6.9% | 20.33K | 18.92K |
| Total | −2K | -$259.62K | ||||||
Derivative Transactions0
No derivative transactions reported